BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2477317)

  • 1. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
    Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
    Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
    Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
    Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent and metastatic cervical cancer with cis-platin, doxorubicin, and cyclophosphamide.
    Hoffman MS; Roberts WS; Bryson SC; Kavanagh JJ; Cavanagh D; Lyman GH
    Gynecol Oncol; 1988 Jan; 29(1):32-6. PubMed ID: 3338661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
    Burke TW; Stringer CA; Morris M; Freedman RS; Gershenson DM; Kavanagh JJ; Edwards CL
    Gynecol Oncol; 1991 Mar; 40(3):264-7. PubMed ID: 2013451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestin therapy in lesions of the endometrium.
    Wentz WB
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
    Hancock KC; Freedman RS; Edwards CL; Rutledge FN
    Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced or recurrent adenocarcinoma of the endometrium with doxorubicin and cyclophosphamide.
    Campora E; Vidali A; Mammoliti S; Ragni N; Conte PF
    Eur J Gynaecol Oncol; 1990; 11(3):181-3. PubMed ID: 2209636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VM-26-vincristine-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent endometrial carcinoma.
    Sorbe B; Wolmesjö E; Frankendal B
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):343-8. PubMed ID: 2915860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
    Cornelison TL; Baker TR; Piver MS; Driscoll DL
    Gynecol Oncol; 1995 Nov; 59(2):243-8. PubMed ID: 7590480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of advanced endometrial cancer].
    Okada H; Yamamoto T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal and systemic chemotherapy for advanced endometrial adenocarcinoma: a case report.
    Vaughn CB; Chapman JL; Herschman BR; Bonczak MJ; Treisman EJ; Groshko GA; Nirenberg PL
    Med Pediatr Oncol; 1990; 18(1):68-71. PubMed ID: 2294393
    [No Abstract]   [Full Text] [Related]  

  • 12. A phase II evaluation of cisplatin, bleomycin, and mitomycin-C in patients with recurrent squamous cell carcinoma of the cervix.
    Hoffman MS; Kavanagh JJ; Roberts WS; LaPolla JP; Fiorica JV; Hewitt S; Cavanagh D
    Gynecol Oncol; 1991 Feb; 40(2):144-6. PubMed ID: 1707024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent and metastatic adenocarcinoma of the endometrium with cisplatin, doxorubicin, cyclophosphamide, and medroxyprogesterone acetate.
    Fung MF; Krepart GV; Lotocki RJ; Heywood M
    Obstet Gynecol; 1991 Dec; 78(6):1033-8. PubMed ID: 1945203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of advanced and recurrent endometrial carcinoma with cyclophosphamide, doxorubicin, 5-fluorouracil, and megestrol acetate.
    Deppe G; Jacobs AJ; Bruckner H; Cohen CJ
    Am J Obstet Gynecol; 1981 Jun; 140(3):313-6. PubMed ID: 7246635
    [No Abstract]   [Full Text] [Related]  

  • 15. Megestrol acetate in the management of advanced endometrial carcinoma.
    Wait RB
    Obstet Gynecol; 1973 Jan; 41(1):129-36. PubMed ID: 4682608
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of cisplatin, adriamycin, and etoposide for metastatic endometrial adenocarcinoma.
    Piver MS; Fanning J; Baker TR
    Am J Clin Oncol; 1991 Jun; 14(3):200-2. PubMed ID: 2031506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemohormone therapy of metastatic melanoma with megestrol acetate plus dacarbazine, carmustine, and cisplatin.
    Nathanson L; Meelu MA; Losada R
    Cancer; 1994 Jan; 73(1):98-102. PubMed ID: 8275444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
    Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
    Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
    Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced and recurrent endometrial cancer with cisplatin, doxorubicin, and cyclophosphamide.
    Dunton CJ; Pfeifer SM; Braitman LE; Morgan MA; Carlson JA; Mikuta JJ
    Gynecol Oncol; 1991 May; 41(2):113-6. PubMed ID: 2050302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.